ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cambrex gets PharmaCore

by Michael McCoy
October 3, 2016 | APPEARED IN VOLUME 94, ISSUE 39

[+]Enlarge
Credit: Cambrex
Cambrex will get this 3,300-m2 facility in North Carolina.
Credit: Cambrex
Cambrex will get this 3,300-m2 facility in North Carolina.

The pharmaceutical chemical maker Cambrex will pay $25 million to acquire PharmaCore, a High Point, N.C.-based developer of small-molecule active pharmaceutical ingredients for clinical trials. PharmaCore has annual sales of $15 million to $17 million and employs nearly 40 chemists, most of whom hold Ph.D.s. Cambrex says the company will complement its large-scale manufacturing facilities in the U.S. and Europe.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment